Table 6.

Simulated Impact of Automated Microscopy Surveillance Results on Antimicrobial Prescribing

Patient No.	Sample	Discontinued	Started	Summary
3	Day 1			No change
5	Day 7	Piperacillin-tazobactam, vancomycin	Amikacin, imipenem
6	Day 1	Imipenem, levofloxacin, vancomycin	Trimethoprim-sulfamethoxazole
	Day 3			No change
8	Day 7	Metronidazole, piperacillin-tazobactam	Vancomycin
	Day 10			No change
17	Day 1			No change
22	Day 3			No change
33	Day 7			No change